-
1 Comment
Vivimed Labs Limited is currently in a long term uptrend where the price is trading 25.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.1.
Vivimed Labs Limited's total revenue rose by 40.6% to $3B since the same quarter in the previous year.
Its net income has dropped by 54.5% to $-495M since the same quarter in the previous year.
Finally, its free cash flow grew by 127.4% to $824M since the same quarter in the previous year.
Based on the above factors, Vivimed Labs Limited gets an overall score of 4/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
ISIN | INE526G01021 |
Exchange | NSE |
CurrencyCode | INR |
Market Cap | 406M |
---|---|
Beta | 1.06 |
PE Ratio | None |
Target Price | 134 |
Dividend Yield | None |
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for VIVIMEDLAB.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025